Evidence map›Paper›PMID 41094274›Full record

ArticleNature methods2025

gReLU: a comprehensive framework for DNA sequence modeling and design.

Avantika Lal, Laura Gunsalus, Surag Nair, Tommaso Biancalani, Gokcen Eraslan

Abstract read
In one paragraph

Article in Nature methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Avantika LalBiology Research | AI Development, gRED Computational Sciences, Genentech, South San Francisco, CA, USA.
Laura Gunsalus *Biology Research | AI Development, gRED Computational Sciences, Genentech, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-3444-5617
Surag Nair *Biology Research | AI Development, gRED Computational Sciences, Genentech, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-6216-2457
Tommaso BiancalaniBiology Research | AI Development, gRED Computational Sciences, Genentech, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-9104-9755
Gokcen EraslanBiology Research | AI Development, gRED Computational Sciences, Genentech, South San Francisco, CA, USA. eraslan.gokcen@gene.com.ORCID http://orcid.org/0000-0001-9579-2909

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep learning models trained on DNA sequences can predict cell-type-specific regulatory activity, reveal cis-regulatory grammar, prioritize genetic variants and design synthetic DNA. However, building and interpreting these models correctly remains difficult, and models and software built by different groups are often not interoperable. Here we present gReLU, a comprehensive software framework that enables advanced sequence modeling pipelines, including data preprocessing, modeling, evaluation, interpretation, variant effect prediction and regulatory element design.

Indexed as

Computational BiologyDNASequence Analysis, DNASoftwareAlgorithmsBase SequenceDeep LearningHumansDNA

Identifiers

PMID41094274
PMCPMC12615257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.